Biotech & MedTech TV



Latest Comments
image_pdfimage_print

Steve Saviuk on Valeo Pharma’s TSX Listing and Q1-22 revenues of $4.2 million, up 128% over Q1-21

In a recent InvestorIntel interview, Tracy Weslosky interviews Valeo Pharma Inc.’s (TSX: VPH | OTCQB: VPHIF) Founder, CEO and Director […]


Dr Jon Gluckman provides an update on Sixth Wave Innovations’ pathogen detection technologies

In a recent InvestorIntel interview, Tracy Weslosky spoke with Dr. Jon Gluckman, President and CEO of Sixth Wave Innovations Inc. (CSE: […]


Jon Gluckman of Sixth Wave Innovations on the increased profitability and decreased carbon emissions from gold mines using its IXOS® product line

In a recent InvestorIntel interview, Tracy Weslosky spoke with Dr. Jon Gluckman, President and CEO of Sixth Wave Innovations Inc. (CSE: […]


Greg Fenton and Byron King discuss Zentek’s highly innovative graphene Icephobic coatings for aircraft and wind turbine lifetime and safety improvement

In a recent InvestorIntel interview, Byron King spoke with Greg Fenton, CEO and Director of Zentek Ltd. (TSXV: ZEN) about […]


Greg Fenton on Zentek’s approval for Nasdaq listing and the expanding use of its highly effective anti-microbial ZenGUARD™ coating

In a recent InvestorIntel interview, Tracy Weslosky spoke with Greg Fenton, CEO and Director of Zentek Ltd. (TSXV: ZEN) about […]


Steve Saviuk of Valeo Pharma on record 2021 revenues, achieving breakeven in 2022, and uplisting on the TSX

In a recent InvestorIntel interview, Tracy Weslosky spoke with Steve Saviuk, CEO of Valeo Pharma Inc. (CSE: VPH | OTCQB: VPHIF) about […]


Mike Druhan of MedX Health on the Launch of Its Teledermatology Screening Platform in the UK

In a recent InvestorIntel interview, Tracy Weslosky spoke with Mike Druhan, President of Dermatology Services at MedX Health Corp. (TSXV: MDX) about MedX […]


David Regan of Sona Nanotech on bringing their rapid saliva Covid-19 test to the market

In a recent InvestorIntel interview, Tracy Weslosky spoke with David Regan, CEO of Sona Nanotech Inc. (CSE: SONA | OTCQB: SNANF) about their […]


Jack Lifton interviews David Regan of Sona Nanotech on its breakthrough, gold nanorod, medical technology

In a recent InvestorIntel interview, Jack Lifton spoke with David Regan, CEO of Sona Nanotech Inc. (CSE: SONA | OTCQB: […]


Thomas Smeenk on Hemostemix products for Your Fountain of Youth

In a recent InvestorIntel interview, Tracy Weslosky spoke with Thomas Smeenk, Co-Founder, President and CEO of Hemostemix Inc. (TSXV: HEM | […]